Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study
Tcj. Sas et al., Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study, PEDIAT RES, 50(3), 2001, pp. 417-422
To assess bone mineral density (BMD) in girls with Turner's syndrome before
and during long-term treatment with GH, longitudinal measurements using ph
alangeal radiographic absorptiometry were performed in 68 girls with Turner
's syndrome. These previously untreated girls, age 2-11 y. participating in
a randomized, dose-response trial, were randomly assigned to one of three
GH dosage groups: group A, 4 IU/m(2)/d (0.045 mg/kg/d); group B. first year
4 IU/m(2)/d, thereafter 6 IU/m(2)/d (approximate to0.0675 mg/kg/d); or gro
up C, first year 4 IU/m(2)/d, second year 6 IU/m(2)/d, thereafter 8 IU/m(2)
/d (approximate to0.090 mg/kg/d), In the first 4 y of GH treatment, no estr
ogens for pubertal induction were prescribed to the girls. Thereafter, girl
s started with 17 beta -estradiol (5 mug/kg body weight/d, orally) when the
y had reached the age of 12 y. Mm results were adjusted for bone age and se
x, and expressed as SD scores using reference values of healthy Dutch girls
. At baseline, almost every individual BMD value of bone consisting predomi
nantly of cortical bone, as well as that of bone consisting predominantly o
f trabecular bone, was within the normal range of healthy girls and the SD
scores were not significantly different from zero [mean (SE) 0.38 (0.22) an
d -0.04 (0.13)]. During 7 y of GH treatment, BMD SD scores showed a signifi
cant increase to values significantly higher than zero [mean (SE) 0.87 (0.1
5) and 0.95 (0.14)]. The increment in BMD SD score of bone consisting predo
minantly of cortical bone was significantly higher in group C compared with
that of the other two GH dosage groups. The pretreatment bone age was sign
ificantly negatively related to the increment in BMD SD score. We found no
significant influence of spontaneous puberty or the use of low-dose estroge
ns in the last 3 y of the study period on the increment in BMD SD score dur
ing 7 y of GH treatment. In conclusion, most untreated young girls with Tur
ner's syndrome have a normal volumetric BMD. During 7 y of GH treatment wit
h 4, 6, or 8 IU/m(2)/d, the BMD SD score increased significantly.